Solid-state 109Ag CP/MAS NMR spectroscopy of some diammine silver(I) complexes

Solid-state cross-polarization magic-angle spinning (CP/MAS) NMR spectra were recorded for the compounds [Ag(NH3)2]2SO4, [Ag(NH3)2]2SeO4 and [Ag(NH3))]NO3, all of which contain the linear or nearly linear two-coordinate [Ag(NH3)2]+ ion. The 109Ag CP/MAS NMR spectra show centrebands and associated spinning sideband manifolds typical for systems with moderately large shielding anisotropy, and splittings due to indirect 1J(109Ag,14N) spin-spin coupling. Spinning sideband analysis was used to determine the 109Ag shielding anisotropy and asymmetry parameters Deltasigma and eta from these spectra, yielding anisotropies in the range 1500-1600 ppm and asymmetry parameters in the range 0-0.3. Spectra were also recorded for 15N and (for the selenate) 77Se. In all cases the number of resonances observed is as expected for the crystallographic asymmetric units. The crystal structure of the selenate is reported for the first time. One-bond (107, 109Ag,15N) coupling constants are found to have magnitudes in the range 60-65 Hz. Density functional calculations of the Ag shielding tensor for model systems yield results that are in good agreement with the experimentally determined shielding parameters, and suggest that in the solid compounds Deltasigma and eta are reduced and increased, respectively, from the values calculated for the free [Ag(NH3)2]+ ion (1920 ppm and 0, respectively), primarily as a result of cation-cation interactions, for which there is evidence from the presence of metal-over-metal stacks of [Ag(NH3)2]+ ions in the solid-state structures of these compounds.     

Simple tricyclohexylphosphine-palladium complexes as efficient catalysts for the Stille coupling of deactivated aryl chlorides

Simple, inexpensive tricyclohexylphosphine adducts of palladium show the highest activity yet observed in the Stille coupling of non-activated and deactivated aryl chlorides.     

Synthesis of an asymmetrical tripodal tetraamine ligand and its five-coordinate copper(II) complex

A simple synthesis has been devised for the tripodal 3,3,4-tetraamine ligand N{(CH2)3NH2}2{(CH2)4NH2} (L). This ligand forms a copper(II) complex, [Cu (LH)Cl2]ClO4 (7), the structure of which has been determined by X-ray diffraction. The cation contains a five-coordinate copper atom, bonded to two chloride ions, the two propylamine groups and the tertiary nitrogen atom of the ligand; the arrangement is a distorted trigonal bipyramid, in which the two primary amine groups occupy the axial positions. The butylamine group of the ligand does not coordinate to copper but is protonated. It is involved in hydrogen bonding to the perchlorate ion. The e.p.r. spectrum of [Cu(dpt)Cl2] is very similar to that of (7), suggesting that it also has a trigonal bipyramidal structure. This revised version was published online in June 2006 with corrections to the Cover Date.     

Synthesis, structure, and magnetism of a new heavy-fermion antiferromagnet, CePdGa6

A new compound, CePdGa₆, and its isostructural analog, LaPdGa₆ have been synthesized by flux growth and characterized by single-crystal X-ray diffraction. The compounds adopt a tetragonal structure with P4/mmm space group, Z=1. The lattice parameters for CePdGa₆ are and and and for LaPdGa₆. Magnetic and thermal measurement have revealed that CePdGa₆ is a heavy-fermion with the specific heat coefficient and Ce f moments order antiferromagnetically along c-axis at . Reconfiguration of spin occurs at to induce a ferromagnetic component only in the a-b plane. This strong anisotropy in the magnetism might be related to its unique layered structure.     

The Suzuki coupling of aryl chlorides in TBAB-water mixtures

Palladium acetate in a mixture of TBAB and water can be used as an effective catalyst for the Suzuki coupling of deactivated aryl chloride substrates.     

Target-templated de novo design of macrocyclic d-/l-peptides: discovery of drug-like inhibitors of PD-1

Peptides are a rapidly growing class of therapeutics with various advantages over traditional small molecules, especially for targeting difficult protein–protein interactions. However, current structure-based methods are largely limited to natural peptides and are not suitable for designing bioactive cyclic topologies that go beyond natural l-amino acids. Here, we report a generalizable framework that exploits the computational power of Rosetta, in terms of large-scale backbone sampling, side-chain composition and energy scoring, to design heterochiral cyclic peptides that bind to a protein surface of interest. To showcase the applicability of our approach, we developed two new inhibitors (PD-i3 and PD-i6) of programmed cell death 1 (PD-1), a key immune checkpoint in oncology. A comprehensive biophysical evaluation was performed to assess their binding to PD-1 as well as their blocking effect on the endogenous PD-1/PD-L1 interaction. Finally, NMR elucidation of their in-solution structures confirmed our de novo design approach.

In silico design of heterochiral cyclic peptides that bind to a specific surface patch on the target protein (PD-1, in this case) and disrupt protein–protein interactions.     

Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets

We have designed four generations of a low molecular weight fragment library for use in NMR-based screening against protein targets. The library initially contained 723 fragments which were selected manually from the Available Chemicals Directory. A series of in silico filters and property calculations were developed to automate the selection process, allowing a larger database of 1.79 M available compounds to be searched for a further 357 compounds that were added to the library. A kinase binding pharmacophore was then derived to select 174 kinase-focused fragments. Finally, an additional 61 fragments were selected to increase the number of different pharmacophores represented within the library. All of the fragments added to the library passed quality checks to ensure they were suitable for the screening protocol, with appropriate solubility, purity, chemical stability, and unambiguous NMR spectrum. The successive generations of libraries have been characterized through analysis of structural properties (molecular weight, lipophilicity, polar surface area, number of rotatable bonds, and hydrogen-bonding potential) and by analyzing their pharmacophoric complexity. These calculations have been used to compare the fragment libraries with a drug-like reference set of compounds and a set of molecules that bind to protein active sites. In addition, an analysis of the overall results of screening the library against the ATP binding site of two protein targets (HSP90 and CDK2) reveals different patterns of fragment binding, demonstrating that the approach can find selective compounds that discriminate between related binding sites.     

Organoruthenaborane Chemistry. X. The SM2-catalysed formation of [ l-(η6-C6Me6)-isocloso-RuB9H9], and some B-phenylamino derivatives. NMR and X-ray diffraction studies

The action of SMe₂ on the ten-vertex nido-ruthenaborane [6-(η⁶-C₆Me₆)RuB₉H_l3] ( 1 ) provides a high-yield route to the unsubstituted isocloso-ruthenaborane [1-(η⁶-C₆Me₆)RuB₉H₉] (2). The benzene analogue [1-(η⁶-C₆Me₆)RuB₉H₉] is prepared similarly. By contrast, reaction of (1) with PhNH₂ gives a variety of B-phenylamino isocloso derivatives, including orange crystals of [1-(η⁶-C₆Me₆)-2-(PhNH)-isocloso-1-RuB 9 H₈] ( 3 ), red-orange [1-(η⁶-C₆Me₆)-2,3-(PhNH)₂-isocloso-1-RuB₉H₇] ( 4 ) and dark-red [1-(η⁶-C₆Me₆)-5,6,7-(PhNH)₃-isocloso-1-RuB₉H₆] ( 5 ). Detailed ¹H and ¹¹B nmr properties of these various compounds are described. The structure of ( 3 ) has been established by a single-crystal X-ray diffraction study of the solvate [1-(η⁶-C₆Me₆)-2-(PhNH)-isocloso-1-RuB₉H₈] · 1/2 CH₂Cl₂; the crystals were monoclinic, space group C2/c, with a = 1895.1(3), b = 1556.6(3), c = 1716.4(3) pm, β = 104.37(1)° and z = 8.     

Absorption,fluorescence and phosphorescence spectra of the singlet and triplet states of s-tetrazine in the crystal and in mixed crystals at low temperatures

The electronic absorption, fluorescence and phosphorescence spectra of s-tetrazine at low temperatures (4.2-1.5 K) are reported and analyzed in the neat crystal and in several mixed crystals. The ³B_3u-¹A_g (nπ^*) origin is at 18414 ± 5 cm^?1 for neat tetrazine. In the mixed crystal several sites identified. The lowest energy origin is at 17453 cm^?1 for tetrazine in pyrazine; 17 701 cm^?1 in pyrimidine; and 17 676 cm^?1 in pyridazine. The ^eB_3u-¹A_g (nπ^*) origin is at 14 096 ± 2 cm^?1 for the neat crystal. The phosphorescence lifetime of neat tetrazine is measured to be 96.8 ± 2.1 μs at 4.2 and 1.8 K. All the spectra are predominately composed of members of progressions in a single totally symmetric mode (ν_6a) built upon site origins and vibrational fundamentals. The ν_6a interval is: 743 (¹A_g), 715 (³B_3u), and 709 cm^?1 (¹B_3u) in the neat tetrazine crystal; 732 (¹A_g) and 705 cm^?1 (¹B_3u in pyrazine host, 737 (¹A_g) and 701 cm^?1 (¹B_3u) in pyrimidine host, and 732 (¹A_g) and 703 cm^?1 (¹B_3u) in pyridazine host mixed crystals. All emission spectra may be analyzed by Oi → (ν″_6a)^o_n (i), i indicating the observed s